Holder & lifecycle

Local holder and regulatory lifecycle structures for pharmaceutical products in Chile.

A local holder model carries ongoing regulatory responsibilities. SERTURNER assesses and structures these arrangements subject to product due diligence, written responsibilities, acceptable risk and confirmed capacity.

Request a due diligence conversation
Due diligence first

A defined holder model, not a nominal address.

Before any role can be accepted, the parties need a controlled view of products, rights, regulatory status, manufacturers, quality and safety interfaces, lifecycle commitments, decision rights and exit arrangements.

Acceptance conditions

  • Complete and authorized product information
  • Acceptable product and counterparty risk
  • Clear quality, safety and escalation interfaces
  • A specific agreement and confirmed SERTURNER capacity
International pharmaceutical professionals reviewing regulatory documents in a structured working session
Aligned responsibilities

Local continuity depends on clear interfaces.

Product, quality, safety and commercial teams need a working model that identifies who decides, who documents and who acts in Chile.

Regulatory continuity

Lifecycle work is explicit and configurable.

Recurring changes, renewals, authority communications and controlled records are included only when expressly listed in an OPERATE catalogue or separate proposal. Acting as local holder is available only for selected engagements and under a separate agreement.

No page, form or initial conversation constitutes holder acceptance.

Next step

Turn the objective into a controlled scope.

Start with non-confidential information. We will identify what is needed to qualify the engagement.

Contact SERTURNER